Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006

Krum, Henry, Jelenik, Michael V., Stewart, Simon, Sindone, Andrew, Atherton, John J., Hawkes, Anna L. and on behalf of the CHF Guidelines Core Writers (2006) Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Medical Journal Of Australia, 185 10: 549-556.


Author Krum, Henry
Jelenik, Michael V.
Stewart, Simon
Sindone, Andrew
Atherton, John J.
Hawkes, Anna L.
on behalf of the CHF Guidelines Core Writers
Title Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006
Journal name Medical Journal Of Australia   Check publisher's open access policy
ISSN 0025-729X
1326-5377
Publication date 2006-11-20
Sub-type Article (original research)
Volume 185
Issue 10
Start page 549
End page 556
Total pages 8
Place of publication Strawberry Hills, NSW, Australia
Publisher Australasian Medical Publishing
Collection year 2006
Language eng
Subject 11 Medical and Health Sciences
Abstract * Chronic heart failure (CHF) is found in 1.5%–2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged ≥ 65 years. * CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years). * Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two-thirds of cases) and idiopathic dilated cardiomyopathy (around 5%–10% of cases). * Diagnosis is based on clinical features, chest x-ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B-type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms. * Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 82 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Wed, 15 Aug 2007, 19:44:05 EST